Meningitis ‘B’ Vaccine – IN STOCK
10the June 2016** WE HAVE MENINGITIS ‘B’ VACCINE IN STOCK
Check out the ‘NEWS’ tab on this website for more information
Meningitis or meningococcal disease is a bacterial disease spread by person to person contact via respiratory secretions or saliva. Meningococcal bacteria are classified in groups on the basis of their outer shell configuration or structure. There are to date 12 distinct groups with historically “B” “C” “W” and “Y” being the most common in UK.
The UK NHS childhood vaccination programme has incorporated meningitis “C” vaccine since the late 1990’s and as a result this form of meningitis has been reduced dramatically with group “B” now accounting for 80% of cases in UK. However since 2009 group “W” has been accounting for an increasing percentage of cases.
There are two other available vaccines, one that protects against serotypes “ACWY” (branded as Menveo® / Nimenrix®) and a new vaccine against the “B” serotype (branded as Bexsero®), ACWY vaccine is available to specific targeted groups via NHS but otherwise is only available privately. It is the vaccine that visitors to Saudi Arabia will require when on a pilgrimage and also to those travelling to the meningitis belt in Sub-Sahara Africa where the main agent is the serotype “A”,
The new meningitis serotype vaccine “B” – Bexsero® is the topic here –
IMPORTANT UPDATE FEBRUARY 2016
PLEASE REFER TO OUR NOTICE CONCERNING THIS VACCINE ON OUR ‘NEWS’ SECTION
Meningitis “B” (Bexsero®) is now available within the NHS childhood programme in babies up to one year old. At this time parents requesting this vaccine for those over 1yr are required to have it privately.
We are now able to offer this vaccine to children and young adults. There is no data for adults over 50yrs and although we can administer to this group we cannot give any level of potential protection.
Since this vaccine likely to induce a temperature, tenderness at the injection site change in eating habits and irritability when administered with other vaccines, separate vaccinations should be considered, but this is not essential. The use of paracetamol reduces the incidence and severity of of fever without diminishing the effective of the vaccine. This should be administered at the time of vaccination or shortly afterwards with subsequent dosing depending on age. The use of other medications other than paracetamol on the immune response has not been studied.
Please contact us for Mengitis B Viral Vaccine in London and surrounding districts. We are in easy reach of Stanmore, Elstree, Radlett, Edgware, Borehamwood, Brookmans Park plus Enfield, Potters Bar, and all of North London districts Finchley, Highgate, Southgate, Muswell Hill. and of course local to us in Whetstone & Barnet. We have no congestion charge and a FREE car park just across the road.
Bexsero® is a relatively new vaccine to UK and we would ask all those who have been vaccinated to report to us or directly to the MHRA any adverse reactions. Please discuss this with the consultant prior to vaccination.